Global Antipsychotic Drugs Market (Brand, Application and Geography)

Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020
Category : Pharmaceuticals
enquire Customize Report

Antipsychotic drugs are also termed as major tranquilizers or neuroleptics and these are primarily used to treat psychosis. The common psychotic disorders, where these drugs are majorly used include schizophrenia, hallucinations, delusions, bipolar disorder and others. The antipsychotic drugs market is expected to grow due to the rising number of Schizophrenic patients. However, patent expiration of major brands could negatively impact the market growth. Deep-dive analysis of global antipsychotic drugs market focuses on major market dynamics such as drivers, restrains and opportunities. Competitive landscape section profiles the key players on the basis of business performance, strategic moves and SWOT analysis. Profound analysis of segments would be helpful to understand the product distribution trends in each segment within the global antipsychotic drugs market.

High prevalence of Schizophrenia and psychotic disorders are the prime drivers for global antipsychotic drugs market. Increased drug abuse, over prescription of drugs and addiction to antipsychotic drugs are the additional factors that drive the market growth for antipsychotic drugs. However, patent expiry of major brands over the past few years had negative impact on market growth and  it has been responsible to the rising competition from generic drug manufacturer. Serious side effects such as tardive dyskinesia, associated with antipsychotics also restraints the market growth. Emerging economies are the opportunistic markets for antipsychotics due to large pool of aging population, which has high risk of psychosis, and increased healthcare awareness. 

Global Antipsychotic Drugs Market by Brands

The global antipsychotic drugs market is segmented into three categories based on brands such as First, Second and Third generation antipsychotic drugs. Except Halodol and lithium carbonate, all first generation antipsychotic agents are called as standard or typical antipsychotics, as they act similar i.e., interference with neurotransmitters. Second generation antipsychotics are also known as atypical antipsychotic agents and act as broad-spectrum antagonists of dopamine, serotonin and alpha-noradrenergic receptors. With development of technology and growing competition to gain largest market share, researchers are focusing on first generation antipsychotics to better understand their working mechanism. Abilify and Seroquel are topmost marketed brands due their high therapeutic efficacy and reduced side effects. 

Global Antipsychotic Drugs Market by Application

The global antipsychotic drugs are used to treat different brain disorders such as Schizophrenia, Bipolar disorder, Dementia, Unipolar Depression and Others. The drugs used in Schizophrenia and psychotic depression are expected to boost the growth of antipsychotic drugs market due to increasing incidences of these two conditions.

Global Antipsychotic Drugs Market by Geography

Geographically, global antipsychotic drugs market is segmented into North America, Europe, Asia-Pacific and LAMEA. Antipsychotics are the largely prescribed drugs in the North American region due to large patient pool suffering from mental and psychotic disorders. Asia-Pacific and LAMEA are the lucrative market for global antipsychotic drugs manufacturers, due to large patient pool and rising healthcare awareness. 

Competitive Landscape

The key players within global antipsychotic drugs market include Eli Lilly, AstraZeneca, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline and Johnson & Johnson. Patent expiration of major brands such as Zyprexa (by Eli Lilly) and Seroquel (by AstraZeneca) has negatively impacted the total revenue of this maket. Generic competition is soaring due to patent expiration of six largest antipsychotic drugs in 2012. 

 High Level Analysis  

The comprehensive analysis of global antipsychotic drugs market provides an overview of the market and its key concerns. Market segmentation is concentric towards product distribution trends of each segment that would be helpful to strategist in deciding on the market segments. Market dynamics covers market drivers, restrains and opportunities, which would help to understand the market behaviour. Porter’s Five Forces analysis would be helpful in determining the market profitability. Buyers bargaining power is high for global antipsychotic drugs market due to patent expiration of major brands and availability of many generic medicines in the marketplace. Global antipsychotic drugs market has high threat from new entrants as major brands have lost their patent protection in 2012. Industrial rivalry is intense due to entry of numerous generic competitors, which forces big players to manipulate their drug prices according to changing market trends. 


  • This report offers the following benefits in particular:

  • Complete analysis of drivers, restrains and opportunities within global antipsychotic drugs market would assist professionals to understand the market behavior 

  • Profound assessment of geography focuses on niche market areas and provides forward looking perspective

  • Porter’s Five Forces framework would assist strategist in decision making by analyzing the market profitability within global antipsychotic drugs market

  • Comprehensive assessment of key leaders and their market strategies for global antipsychotic drugs market would be informative to professionals in the corporate sector 


The global antipsychotic drugs market is segmented into two major categories such as technology and geography. 


  • First Generation Drugs (Standard / Typical Antipsychotic Agents) 

    • Thorazine (Chlorpromazine HCl) 

    • Serentil (Mesoridazine Besylate) 

    • Mellaril (Thioridazine HCl) 

    • Haldol (Haloperidol) 

    • Loxitane (Loxapine Succinate) 

    • Trilafon (Perphenazine)

    • Navane (Thiothixene) 

    • Sordinol (Clopenthixol)

    • Others

  • Second generation Drugs  (Atypical Antipsychotic Agents)

    • Zyprexa (Olanzapine) 

    • Geodon (Ziprasidone) 

    • Seroquel (Quetiapine) 

    • Risperdal (Risperidone)

    • Clozaril (Clozapine)

    • Invega (Paliperidone) 

    • Asendin (Amoxapine)

    • Latuda (Lurasidone)

    • Others

  • Third generation Drugs 

    • Abilify (Aripiprazole)


  • Schizophrenia

  • Bipolar Disorder

  • Dementia

  • Unipolar Depression

  • Other


  • North America

The Report is under production. Please fill in the form below to request for a TOC

* Marked Fields are Mandatory
Name * :
Email ID * :
Name of Company :
Country :
Phone No * :
Message :
Security code * :
Can't read the image? click here to refresh
Publisher Name : Allied Market Research

Published Reports
About Spinal Fusion Spinal fusion surgery is performed in many forms, and all are designed to help limit the pain caused by joints through surgery depending on conditions such as degenerative disc disease (DDD), spondylosyndesis or spondylodesis, and other small problems caused in spine vertebrae. Spine ....
US $2500
About Cystic Fibrosis Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited, chronic disease and is progressive in nature. The onset of cystic fibrosis typically occurs in early childhood or, rarely, at birth. The primary symptoms of cystic fibrosis include breathing difficulties, ....
US $2500
Summary Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of ....
US $1495

Upcoming Reports
Clinical nutrition products are type of pharmaceutical products, which help to keep patient healthy. They aid to improve metabolic system of the body by providing adequate supplements such as minerals, vitamins and others .
US $ 4148
Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) indicates APIs market gaining traction .
US $ 4148
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Opportunities and Forecasts, 2014 - 2020
US $2850
Please Select Format
Single User : US $ 4148
Five User: US $ 5171
Enterprise User: US $ 7219
Data Pack :- US $ 3840

market research offer
Contact us
Call us +1-971-202-1575
--- or ---
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.